Keyword Connections

cancer immunotherapy

Journals

7

1 Viruses

2 journal of leukocyte biology

3 thrombosis and haemostasis

4 genome medicine

5 drug delivery and translational research

6 xi bao yu fen zi mian yi xue za zhi = chinese journal of cellular and molecular immunology

7 international review of cell and molecular biology

Research Groups

0

No Research Group Connected

Bibliographies

62

1 Intracellular RNA Sensing in Mammalian Cells: Role in Stress Response and Cancer Therapies.

2 Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4.

3 High-Content Immunophenotyping and Hierarchical Clustering Reveal Sources of Heterogeneity and New Surface Markers of Human Blood Monocyte Subsets.

4 [Increased percentage and defective inhibitory function of CD4CD25FOXP3 T cells in synovial fluid of patients with rheumatoid arthritis].

5 The Susceptibility of Human Melanoma Cells to Infection with the Leningrad-16 Vaccine Strain of Measles Virus.

6 cancer immunotherapies targeting the pd-1 signaling pathway

7 review of cancer immunotherapy: application of chimeric antigen receptor t cells and programmed death 1/programmed death-ligand 1 antibodies

8 preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to n-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer

9 toll-like receptor 3 signal in dendritic cells benefits cancer immunotherapy

10 dendritic cell therapies for hematologic malignancies

11 immunoediting and antigen loss: overcoming the achilles heel of immunotherapy with antigen non-specific therapies

12 capitalizing on cancer specific replication: oncolytic viruses as a versatile platform for the enhancement of cancer immunotherapy strategies

13 pathological mobilization and activities of dendritic cells in tumor-bearing hosts: challenges and opportunities for immunotherapy of cancer

14 dying to be noticed: epigenetic regulation of immunogenic cell death for cancer immunotherapy

15 cancer immunotherapy: lights and shadows

16 antimicrobial peptides as biologic and immunotherapeutic agents against cancer: a comprehensive overview

17 Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways

18 Mechanisms of Intrinsic Tumor Resistance to Immunotherapy

19 PD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression

20 Amplifying STING activation by biomimetic manganese mRNA nanovaccines for local and systemic cancer immunotherapy.

21 Tebentafusp elicits on-target cutaneous immune responses driven by cytotoxic T-cells in uveal melanoma patients.

22 The evolving landscape of oncolytic virus immunotherapy: combinatorial strategies and novel engineering approaches.

23 Virtual Clinical Trial Reveals Significant Clinical Potential of Targeting Tumor-Associated Macrophages and Microglia to Treat Glioblastoma.

24 Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression.

25 A synergistic cancer immunotherapy nano-system for preventing tumor growth

26 Design and application of oncolytic viruses for cancer immunotherapy

27 Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy

28 Heat Shock Proteins in Cancer Immunotherapy.

29 High-Throughput Screening Assays for Cancer Immunotherapy Targets: Ectonucleotidases CD39 and CD73.

30 miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy.

31 Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing

32 Next-Generation Cancer Immunotherapy Targeting Glypican-3

33 the rise of allogeneic natural killer cells as a platform for cancer immunotherapy: recent innovations and future developments

34 vaccines for cancer immunotherapy: an evidence-based review on current status and future perspectives

35 harnessing the microbiome to enhance cancer immunotherapy

36 cancer immunotherapy and identification of prognostic and predictive biomarkers

37 cancer immunotherapy: historical perspective of a clinical revolution and emerging preclinical animal models

38 targeting nk cells for anti-cancer immunotherapy: clinical and pre-clinical approaches

39 toll-like receptor-4 modulation for cancer immunotherapy

40 glatiramer acetate, dimethyl fumarate and monomethyl fumarate up-regulate the expression of ccr10 on the surface of natural killer cells and enhance their chemotaxis and cytotoxicity. implications for cancer immunotherapy

41 induced pluripotent stem cell as a new source for cancer immunotherapy

42 gene expression profile of dendritic cell-tumor cell hybrids determined by microarrays and its implications for cancer immunotherapy

43 cancer immunotherapy by targeting ido1/tdo and their downstream effectors

44 Immunology of Cell Death in Cancer Immunotherapy

45 Addressing current challenges in cancer immunotherapy with mathematical and computational modeling

46 Molecular MRI-Based Monitoring of Cancer Immunotherapy Treatment Response

47 Optimal control in cancer immunotherapy by the application of particle swarm optimization

48 Approximate Analytical Solution of a Cancer Immunotherapy Model by the Application of Differential Transform and Adomian Decomposition Methods

49 Pattern Formation as a Resilience Mechanism in Cancer Immunotherapy

50 T cell equation as a conceptual model of T cell responses for maximizing the efficacy of cancer immunotherapy

51 Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

52 Nanotechnology for Boosting Cancer Immunotherapy and Remodeling Tumor Microenvironment: The Horizons in Cancer Treatment.

53 Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment

54 Lung cancer immunotherapy: progress, pitfalls, and promises

55 Addressing current challenges in cancer immunotherapy with mathematical and computational modeling

56 Molecular MRI-Based Monitoring of Cancer Immunotherapy Treatment Response

57 Approximate Analytical Solution of a Cancer Immunotherapy Model by the Application of Differential Transform and Adomian Decomposition Methods

58 MANIFEST: Multiomic Platform for Cancer Immunotherapy.

59 Pattern Formation as a Resilience Mechanism in Cancer Immunotherapy

60 T cell equation as a conceptual model of T cell responses for maximizing the efficacy of cancer immunotherapy

61 Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy.

62 Intestinal Microbiome Modulation of Therapeutic Efficacy of Cancer Immunotherapy.